{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:57:01Z","timestamp":1781675821244,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the favorable toxicity profiles of whole breast radiotherapy, there are subgroups that tend to experience high toxicity. This study examines anatomical and physiological characteristics that can predict the induction of toxicity for skin and edema.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the present cohort, we examined 387 patients who received only radiation therapy to the breast, did not receive chemotherapy, and whose planning data could be fully constructed for evaluation. Metric parameters of the therapy that correlate directly with physiological\/anatomical characteristics, such as the irradiated PTV and the boost volume, were evaluated. We also measured breast gland density in a defined reference structure (surrogate Parameter). We compared the parameters collected between patients who experienced grade II toxicity after therapy and patients who experienced grade I or less toxicity from the therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was a significant correlation between volume and grade II toxicity for both skin toxicity and edema formation. There was also a higher risk of grade II for the surrogate marker in patients with a HU of less than \u2212\u200959. The multivariable model for the parameters confirms the volume of the PTV and the boost as risk factors, but not the HU of less than 59.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is evidence of a correlation between breast volume, the density of breast tissue and the resulting toxicity of adjuvant radiotherapy in breast cancer. Multivariate analyses were not statistically significant in the retrospective cohort study, and further research is required. Taking these factors into account could further improve treatment tolerance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-026-02833-w","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:36:30Z","timestamp":1774686990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between radiation volume and breast density for skin toxicity and breast edema after radiotherapy in breast conserving therapy of breast cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Mathias","family":"Sonnhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melsa","family":"Oyur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Nicklas","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Michael","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric Oliver","family":"Carl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Maximilian","family":"Blach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"4","key":"2833_CR1","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/j.clbc.2021.11.008","volume":"22","author":"A Fodor","year":"2022","unstructured":"Fodor A, et al. Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients. Clin Breast Cancer. 2022;22(4):e480\u20137.","journal-title":"Clin Breast Cancer"},{"issue":"15","key":"2833_CR2","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1200\/JCO.2017.72.2660","volume":"35","author":"SF Shaitelman","year":"2017","unstructured":"Shaitelman SF, Howell RM, Smith BD. Effects of Smoking on Late Toxicity From Breast Radiation. J Clin Oncol. 2017;35(15):1633\u20135.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2833_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13014-025-02614-x","volume":"20","author":"AA D\u00edaz-Gavela","year":"2025","unstructured":"D\u00edaz-Gavela AA, et al. Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer. Radiat Oncol. 2025;20(1):45.","journal-title":"Radiat Oncol"},{"issue":"2","key":"2833_CR4","first-page":"144","volume":"35","author":"DE McGhee","year":"2020","unstructured":"McGhee DE, Steele JR. Breast Biomechanics: What Do We Really Know? Physiol. 2020;35(2):144\u201356.","journal-title":"Breast Biomechanics: What Do We Really Know? Physiol"},{"issue":"14","key":"2833_CR5","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3390\/cancers17142368","volume":"17","author":"MR Oyur","year":"2025","unstructured":"Oyur MR, et al. Breast Edema After Breast-Conserving Surgery and Radiotherapy: Introduction of a Clinically Meaningful Classification and Evaluation of the Incidence After Normo- and Hypofractionated Treatments. Cancers. 2025;17(14):2368.","journal-title":"Cancers"},{"issue":"1","key":"2833_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","volume":"47","author":"A Trotti","year":"2000","unstructured":"Trotti A, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(1):13\u201347.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2833_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-018-1022-1","volume":"13","author":"A Fogliata","year":"2018","unstructured":"Fogliata A, et al. Evaluation of target dose inhomogeneity in breast cancer treatment due to tissue elemental differences. Radiat Oncol. 2018;13(1):92.","journal-title":"Radiat Oncol"},{"issue":"3","key":"2833_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00066-021-01839-5","volume":"198","author":"MN Duma","year":"2022","unstructured":"Duma MN, et al. Breast clinical target volume: HU-based glandular CTVs and ESTRO CTVs in modern and historical radiotherapy treatment planning. Strahlenther Onkol. 2022;198(3):229\u201335.","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"2833_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues. Int J Radiat Oncol Biol Phys. 2010;76(3):S3\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2833_CR10","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1016\/j.ijrobp.2015.07.637","volume":"93","author":"JD Murphy","year":"2015","unstructured":"Murphy JD, et al. Guidelines and Predicted Cardiac Mortality Among Breast Cancer Patients. Int J Radiat Oncol Biol Phys. 2015;93(3):E37.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"2833_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086\u201394.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2833_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s13193-023-01725-9","volume":"14","author":"M Ibrahim","year":"2023","unstructured":"Ibrahim M, Habashy H, Monib S. Iatrogenic Breast Lymphoedema: Incidence, Diagnosis, and Associated Risk Factors. Indian J Surg Oncol. 2023;14(3):637\u201343.","journal-title":"Indian J Surg Oncol"},{"issue":"8","key":"2833_CR13","first-page":"515","volume":"27","author":"D Kedar","year":"2025","unstructured":"Kedar D, et al. Prevalence of Breast Edema Following Conservative Breast Therapy in Israeli Patients. Isr Med Assoc J. 2025;27(8):515\u20139.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"2833_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13014-025-02584-0","volume":"20","author":"C Zhong","year":"2025","unstructured":"Zhong C, et al. Sequential or simultaneous-integrated boost in early-stage breast cancer patients: trade-offs between skin toxicity and risk of compromised coverage. Radiat Oncol. 2025;20(1):10.","journal-title":"Radiat Oncol"},{"issue":"2","key":"2833_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canrad.2008.11.009","volume":"13","author":"M Botti","year":"2009","unstructured":"Botti M, et al. La radioth\u00e9rapie mammaire hypofractionn\u00e9e en 13 s\u00e9ances, parfaite tol\u00e9rance ou r\u00e9action cutan\u00e9e d\u00e9cal\u00e9e ? \u00c9tude prospective de l\u2019institut Curie. Cancer\/Radioth\u00e9rapie. 2009;13(2):92\u20136.","journal-title":"Cancer\/Radioth\u00e9rapie"},{"issue":"2","key":"2833_CR16","doi-asserted-by":"publisher","first-page":"104612","DOI":"10.1016\/j.canrad.2025.104612","volume":"29","author":"J Bouziane","year":"2025","unstructured":"Bouziane J, et al. Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: Excellent early tolerance or delayed skin reactions? Real life experience. Cancer\/Radioth\u00e9rapie. 2025;29(2):104612.","journal-title":"Cancer\/Radioth\u00e9rapie"},{"issue":"2","key":"2833_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0940-9602(02)80016-4","volume":"184","author":"E Vandeweyer","year":"2002","unstructured":"Vandeweyer E, Hertens D. Quantification of glands and fat in breast tissue: an experimental determination. Ann Anat. 2002;184(2):181\u20134.","journal-title":"Ann Anat"},{"issue":"1","key":"2833_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12282-016-0694-3","volume":"24","author":"I Meattini","year":"2017","unstructured":"Meattini I, et al. Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer. Breast Cancer. 2017;24(1):52\u201362.","journal-title":"Breast Cancer"},{"issue":"3","key":"2833_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10549-011-1789-3","volume":"131","author":"X Sun","year":"2012","unstructured":"Sun X, et al. Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat. 2012;131(3):1003\u201312.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"2833_CR20","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1080\/00140139.2017.1330968","volume":"60","author":"CE Coltman","year":"2017","unstructured":"Coltman CE, Steele JR, McGhee DE. Breast volume is affected by body mass index but not age. Ergonomics. 2017;60(11):1576\u201385.","journal-title":"Ergonomics"},{"issue":"2","key":"2833_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10549-012-2362-4","volume":"137","author":"S Antoni","year":"2013","unstructured":"Antoni S, et al. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat. 2013;137(2):337\u201347.","journal-title":"Breast Cancer Res Treat"},{"key":"2833_CR22","doi-asserted-by":"crossref","unstructured":"Mori M, et al. Breast density histogram analysis: the role of fat in outcome prediction after whole breast radiotherapy. Pract Radiat Oncol; 2025.","DOI":"10.2139\/ssrn.5240655"},{"key":"2833_CR23","doi-asserted-by":"publisher","first-page":"104694","DOI":"10.1016\/j.breast.2026.104694","volume":"85","author":"T Jaikuna","year":"2026","unstructured":"Jaikuna T, et al. Breast composition and dose deposition to fat and fibroglandular tissues are associated with breast side effects after radiation therapy. Breast. 2026;85:104694.","journal-title":"Breast"},{"issue":"10099","key":"2833_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","volume":"390","author":"CE Coles","year":"2017","unstructured":"Coles CE, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390(10099):1048\u201360.","journal-title":"Lancet"},{"issue":"7","key":"2833_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1470-2045(25)00194-9","volume":"26","author":"AM Kirby","year":"2025","unstructured":"Kirby AM, et al. Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol. 2025;26(7):898\u2013910.","journal-title":"Lancet Oncol"},{"key":"2833_CR26","doi-asserted-by":"publisher","first-page":"m2836","DOI":"10.1136\/bmj.m2836","volume":"370","author":"JS Vaidya","year":"2020","unstructured":"Vaidya JS, et al. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ. 2020;370:m2836.","journal-title":"BMJ"},{"issue":"10394","key":"2833_CR27","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/S0140-6736(23)00619-0","volume":"401","author":"CE Coles","year":"2023","unstructured":"Coles CE, et al. Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial. Lancet. 2023;401(10394):2124\u201337.","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1186\/s13014-026-02849-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000}}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02833-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:36:18Z","timestamp":1781674578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02833-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2833"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02833-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13014-026-02849-2","URL":"https:\/\/doi.org\/10.1186\/s13014-026-02849-2","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Hanover Medical School (protocol code Nr. 10516_BO_K_2022 and 17 August 2022 of approval).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}},{"value":"Informed consent was obtained from all subjects involved in this study. The patient has given her consent for the use of the clinical image datasets. This consent may be obtained from the corresponding author upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}